Compound ID | 342
Synonym(s): MC-04,546
Class: Beta-lactam (cephalosporin)
| Spectrum of activity: | Gram-negative |
| Details of activity: | Cell wall inhibitors; active against a broad spectrum of Gram positive bacteria including resistant strains such as MRSA but not MRCR S. aureus |
| Combined with other compounds: | Could be combined with aztreonam, fosfomycin, gentamicin or levofloxacin for empiric therapy |
| Institute where first reported: | Microcide Pharmaceuticals; Essential Therapeutics, USA (Ceased) |
| Year first mentioned: | 2000 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| Reason Dropped: | Essential Therapeutics closed down in 2004 |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/135529042 |
| Citation: | https://www.sciencedirect.com/science/article/pii/S0968089602004315?via%3Dihub |